Immunomodulation of experimental antiphospholipid syndrome

Y. Sherer, M. Blank, Y. Shoenfeld

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

The various therapeutic modalities which are found to be beneficial in experimental antiphospholipid syndrome include: bone marrow transplantation, anti-CD4 monoclonal antibodies, bromocriptine, intravenous immunoglobulins and anti-idiotypes, interleukin-3, and various anti-coagulant and anti-aggregate agents. The advantage of animal models is the ability to evaluate experimental treatments that cannot be tested directly on patients. In this paper, we review the effect of these agents on animal models of antiphospholipid syndrome, their mechanisms of action, and their clinical implications.

Original languageEnglish
Pages (from-to)48-52
Number of pages5
JournalScandinavian Journal of Rheumatology, Supplement
Volume27
Issue number107
DOIs
StatePublished - 1 Jan 1998

Fingerprint

Dive into the research topics of 'Immunomodulation of experimental antiphospholipid syndrome'. Together they form a unique fingerprint.

Cite this